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SUMMARY
RNA-binding proteins (RBPs) and long non-coding
RNAs (lncRNAs) are key regulators of gene expres-
sion, but their joint functions in coordinating cell
fate decisions are poorly understood. Here we
show that the expression and activity of the RBP
TDP-43 and the long isoform of the lncRNA Neat1,
the scaffold of the nuclear compartment ‘‘para-
speckles,’’ are reciprocal in pluripotent and differen-
tiated cells because of their cross-regulation. In
pluripotent cells, TDP-43 represses the formation of
paraspeckles by enhancing the polyadenylated short
isoform of Neat1. TDP-43 also promotes pluripo-
tency by regulating alternative polyadenylation of
transcripts encoding pluripotency factors, including
Sox2, which partially protects its 30 UTR from miR-
21-mediated degradation. Conversely, paraspeckles
sequester TDP-43 and other RBPs from mRNAs and
promote exit from pluripotency and embryonic
patterning in the mouse. We demonstrate that
cross-regulation between TDP-43 and Neat1 is
essential for their efficient regulation of a broad
network of genes and, therefore, of pluripotency
and differentiation.
INTRODUCTION
A long noncoding RNA (lncRNA) called NEAT1 acts as a scaffold
for paraspeckles by recruiting many RNA-binding proteins
(RBPs) that have been implicated in development, cancer, and
neurodegeneration, including TDP-43 and FUS (West et al.,
2016). Paraspeckles have been implicated in post-transcrip-
tional regulation by association with specific mRNAs and
RBPs (Chen and Carmichael, 2009; Hennig et al., 2015; Jiang
et al., 2017; Naganuma et al., 2012; Prasanth et al., 2005).
Remarkably, paraspeckles have been identified in many types
of somatic cells but not in embryonic stem cells (ESCs) (Chen
and Carmichael, 2009). Several lncRNAs and RBPs can affect
differentiation of ESCs by regulating gene expression (Flynn
and Chang, 2014), but the role of their cross-regulation in pro-
moting efficient transitions during differentiation is unknown.
Thus, investigating the recruitment of specific RBPs by NEAT1
into paraspeckles in the context of ESC differentiation can
answer the larger question of how the scaffolding of RBPs by
lncRNAs is coupled to cell fate transitions and how this might
coordinate the broader gene regulatory networks that establish
distinct cell identities.
Here we reveal the importance of cross-regulation between
NEAT1 and TDP-43 in the context of cellular differentiation. We
find that an evolutionarily conserved switch in alternative polya-
denylation (APA) of NEAT1 is regulated by TDP-43 and leads
to induction of the long isoform (NEAT1_2), which scaffolds
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paraspeckles upon exit from pluripotency. We also show that
TDP-43 and NEAT1_2 have opposing functions during differen-
tiation because of their cross-regulation: TDP-43 represses the
formation of paraspeckles in pluripotent cells, whereas NEAT1
partly sequesters TDP-43 away from mRNAs in differentiated
cells. TDP-43 also globally regulates the APA of many mRNAs
encoding pluripotency regulators, including the core pluripo-
tency and reprogramming factor Sox2. We demonstrate that
their cross-regulation is essential for the efficient functions of
TDP-43 andNeat1 in promoting states of pluripotency and differ-
entiation, respectively. This shows how a lncRNA can act
together with cross-regulated RBPs to increase the efficiency
of cell fate transitions.
RESULTS
APA Induces Formation of Paraspeckles upon Exit from
Pluripotency
The NEAT1 gene produces two transcripts, a short isoform that
is polyadenylated and does not form paraspeckles (NEAT1_1)
and a full-length isoform that ends with a triple helix and forms
paraspeckles that scaffold various RBPs (NEAT1_2) (Li et al.,
2017; Naganuma et al., 2012). We quantified NEAT1 foci in hu-
man ESCs (hESCs) that were prompted to differentiate to diverse
fates using single-molecule fluorescence in situ hybridization
(FISH) probes that recognized either the region common to
both isoforms or the region specific to NEAT1_2 (Figure S1A).
We observed a dramatic lineage-independent increase in the
number of NEAT1_2 foci in the early trophoblast-, mesoderm,
mesendoderm-, and neuroectoderm-differentiated progeny of
hESCs (Figure 1A; Figure S1B) and determined that removal of
pluripotency medium (spontaneous differentiation) is sufficient
to trigger paraspeckle formation (Figure 1A). As evidence of a
conserved mechanism, removal of pluripotency maintenance
factors (2iLIF) from the medium was also sufficient to trigger
paraspeckle formation in mouse ESCs (mESCs) (Figure 1B;
Figure S1C).
To gain insights into the mechanism that contributes to
NEAT1 dynamics, we sequenced RNAs from undifferentiated
hESCs and their progeny. Sequencing of nascent RNA
(nascent RNA-seq) by selecting for transcripts pulse-labeled
with ethynyl uridine revealed that NEAT1_1 is expressed in
undifferentiated hESCs, and NEAT1_2 was found among the
18 transcripts that were commonly upregulated within 24 h
differentiation treatment by WNT3A, a small-molecule inhibitor
of GSK3 (CHIR99021), and BMP4 (Figure 1C; Figure S1D; Ta-
ble S1). As reported for somatic cells (Mao et al., 2011; Shevt-
sov and Dundr, 2011), we found that NEAT1_2 is localized to
the chromatin, whereas NEAT1_1 is localized to the nucleo-
plasm (Figures S1E–S1J). To determine whether the expres-
sion of NEAT1 is post-transcriptionally regulated, we used
CRISPR/Cas9-mediated editing to delete the internal polyade-
nylation (DpA) site of NEAT1 in hESCs and of Neat1 in mESCs.
We found that this induced the production of NEAT1_2 in
undifferentiated hESCs or mESCs (Figures 1D, 1E, S2A,
and S2B).
We found previously that NEAT1 is strongly bound by TDP-43
in somatic cells (Tollervey et al., 2011), which led us to inquire
whether this RBP regulates NEAT1. Indeed, we found that over-
expression of TDP-43 repressed paraspeckle formation upon
spontaneous differentiation of mESCs (Figure 1B; Figure S1C).
Conversely, depletion of TDP-43 induced the production
NEAT1_2 and paraspeckle formation in hESCs or mESCs to a
similar extent as deletion of the pA site, as detected by single-
molecule imaging and RNA-seq (Figures 1D–1F; Figure S2C).
We conclude that the isoform switch of NEAT1 is regulated by
TDP-43 to coincide with the exit from pluripotency, ensuring
that NEAT1_2 scaffolds paraspeckles upon differentiation irre-
spective of the embryonic lineage.
NEAT1_2 Recruits TDP-43 into Paraspeckles and Away
From mRNAs
Because TDP-43 is a knownparaspeckle RBP (West et al., 2016),
we next asked whether reciprocal regulation by NEAT1_2 on
TDP-43 takes place upon early differentiation. We used a global
mRNA-RBP occupancy analysis (Baltz et al., 2012; Castello
et al., 2012) to examine how induction ofNEAT1_2 in the undiffer-
entiated state of NEAT1DpA hESCs affects the binding of RBPs
to polyadenylated mRNAs (Figure 1D; Figures S2D and S2E).
Because NEAT1_2 is not polyadenylated, it remains present in
the supernatant after the removal of polyadenylatedmRNAs (Fig-
ure S2F). Thus, the RBPs that are recruited to paraspeckles and
crosslinked to NEAT1_2 in NEAT1DpA hESCs are not expected
to co-purify with polyadenylated mRNAs, and, as a result, their
mRNA occupancy is expected to decrease (Figure 2A). Indeed,
the mRNA occupancy of known paraspeckle proteins, including
TDP-43, NONO, SFPQ, RBM14, HNRNPH3, HNRNPK, FUS,
and DAZAP1 (Fox et al., 2018), was decreased in NEAT1DpA
hESCs (Figure 2B; Figure S2G; Table S2), demonstrating that
induction of NEAT1_2 indeed leads to partial recruitment of a
cohort of RBPs into paraspeckles and away from mRNAs. In
addition, we found that TDP-43, but not control RBPs, was
increasingly retained in the supernatant after depletion of polya-
denylatedmRNAs inNEAT1DpA hESCs (Figure 2C), confirming a
role of NEAT1_2 in sequestering TDP-43 into paraspeckles.
TDP-43 is known to be localized to the outer shell of para-
speckles (Naganuma et al., 2012; West et al., 2016), but it has
been unclear whether TDP-43 needs to bind to NEAT1_2 to
localize to paraspeckles. The NEAT1_2 isoform contains three
regions rich in UGUG repeats that overlap with the main peaks
of TDP-43 binding (Tollervey et al., 2011). We used CRISPR-
Cas9 editing in the HAP1 cell line, which forms paraspeckles in
the steady state, to delete these three regions from the endoge-
nous NEAT1 gene (Figure 2D; NEAT1DUG) that are not essential
for paraspeckle assembly (Yamazaki et al., 2018). We confirmed
that NEAT1 foci formation and assembly of PSPC1 in para-
speckles remained intact in NEAT1DUG cells (Figure 2E). In
contrast, localization of TDP-43 into paraspeckles dramatically
decreased in NEAT1DUG cells (Figures 2F and 2G). To confirm
that the UGUG-rich repeats in theNEAT1_2 isoform are essential
for the localization of TDP-43 to paraspeckles, we inserted
a stretch of 60 UG-repeats to the 30 end of endogenous
NEAT1DUG (Figure 2H), which restored the colocalization of
TDP-43 with paraspeckles (Figures 2I and 2J). Taken together,
our findings indicate that TDP-43 localizes to paraspeckles
because of its direct binding to the NEAT1_2 isoform, which
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Figure 1. Alternative Polyadenylation of NEAT1 Induces Paraspeckle Formation upon Differentiation and Depletion of TDP-43 in Mouse and
Human ESCs
(A and B) The number of paraspeckles analyzed by counting NEAT1_1, NEAT1_2 (A) or Neat1_1, Neat1_2 (B) double-labeled foci (based on single-molecule
fluorescent in situ hybridization [smFISH] and criteria explained in Figure S1A).
(A) Undifferentiated hESCs, spontaneously differentiating cells, and BMP4-, CHIR99021-, WNT3A-, and retinoic acid (RA)-treated cells, promoting trophoblast,
mesoderm, mesendoderm (primitive streak-like), and neuroectoderm fates, respectively.
(B) Undifferentiated mESCs and spontaneously differentiating iTDP-43-EGFPmESCs untreated or treated with doxycycline to ectopically express TDP-43; more
than 250 (A) and more than 200 (B) cells analyzed per group, Mann-Whitney U test; **p < 0.001, ***p < 0.0001. Duration of treatment was as indicated.
(C) Venn diagram depicting differentially expressed genes in hESCs exposed to the indicated differentiation stimuli for 24 h relative to untreated cells (n = 2
biological replicates of global RNA-seq per condition; adjusted p < 0.01, Fisher’s exact test, fold changeR 4). Bottom: representative mapping of NEAT1 RNA-
seq reads aligned to the two isoforms; global and nascent RNA-seq of undifferentiated hESCs and CHIR99021-treated hESCs (n = 2 biological replicates).
(D and E) Percentage and representative maximum projection photomicrographs of h/mESCs exhibiting NEAT1_1, NEAT1_2 (D) and Neat1_1, Neat1_2 (E)
isoforms analyzed as above.
(D) Undifferentiated WT and NEAT1DpA line and 3-day TDP-43 small interfering RNA (siRNA)-treated hESCs (knockdown [KD]) maintained under pluripotency
conditions.
(E) UndifferentiatedWT andNeat1DpA line and cTdp-43 KO (conditional knockout) mESCs 3 days following tamoxifen treatment, which leads to deletion of Tdp-43
under pluripotency conditions. Statistical analysis and counting as in (A); scale bars, 10 mm. Red, NEAT1_1, _2, Neat1_1, _2 probes; blue, DAPI (nuclear stain).
(F) Representative mapping of NEAT1 and Neat1 RNA-seq reads displaying samples from TDP-43 siRNA KD or control siRNA-treated hESCs (2 days) and
untreated or tamoxifen-treated Tdp-43 KO mESCs (2 days, n = 3 biological replicates) under pluripotency conditions.
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partially reduces its binding to polyadenylated RNAs upon para-
speckle formation.
TDP-43 Maintains Pluripotency and Enhances Somatic
Cell Reprogramming
The role of TDP-43 in suppressing paraspeckle formation in
undifferentiated hESCs or mESCs and TDP-43 sequestration in
differentiated cells suggested that it might be regulating pluripo-
tency. To directly examine this, we extracted transcript abun-
dance from 30 mRNA-seq of conditional Tdp-43 knockout
(cTdp-43 KO) mESCs (Chiang et al., 2010; Figure S2C). This
demonstrated that many general pluripotency genes, as defined
by a previous study (Kalkan et al., 2017), were significantly down-
regulated, whereas genes that collectively classify trophecto-
derm differentiation were upregulated (Figure 3A; Table S3).
The only significantly upregulated pluripotency gene was
Lin28a, but this is consistent with the fact that expression of
Lin28a increases immediately after the exit from naive pluripo-
tency (Kalkan et al., 2017). Destabilization of pluripotency was
also evident by the loss of the dome-shaped compact colony
morphology in cTdp-43 KOmESCs (Figure 3B). In contrast, over-
expression of TDP-43 promoted pluripotency, as indicated by
prolonged expression of SSEA-1 and elevated NANOG upon
spontaneous differentiation of mESCs (Figures 3C and 3D).
To analyze this further, we next tested whether overexpression
of TDP-43 affects reprogramming of human secondary fibroblasts
harboring a doxycycline-inducible OKSM (OCT4, KLF4, SOX2,
C-MYC) gene cassette (Cacchiarelli et al., 2015; Figure 3E). We
found that this results in a nearly 2-fold increase in the number
of colonies expressing the pluripotency marker alkaline phospha-
tase (AP) and a 3-fold increase in cells expressing the pluripotency
marker TRA-1-60 (Figures 3F–3I), indicating that TDP-43 facili-
tates reprogramming. Moreover, transient ectopic expression of
TDP-43 during the initial phase of reprogramming of primary adult
human fibroblasts led to a 5-fold increase in the number of
induced pluripotent stem cell (iPSC) colonies (Figures 3J and 3K).
TDP-43 Regulates APA of Many Transcripts Important
for Pluripotency, Including SOX2
To further understand the mechanisms whereby TDP-43 pro-
motes pluripotency, we analyzed its global role in pA site selec-
tion, which is plausible given our previous findings regarding
TDP-43’s direct regulation of APA (Rot et al., 2017). We used
30 mRNA-seq to compare undifferentiated hESCs with meso-
dermal progenitors that were differentiated by activating the
Wnt or b-catenin pathway using a GSK3 inhibitor (Blauwkamp
et al., 2012). We confirmed the enrichment of mesoderm gene
signature and downregulation of pluripotency genes in the pro-
genitor population by RNA-seq (Figure S3A; Table S4). We also
confirmed the validity of the pA sites identified by 30 mRNA-
seq (Figures S3B–S3F). In genes that contained multiple pA
sites, we defined the two pA sites with the most significant
change between mesodermal progenitors and undifferentiated
hESCs. Importantly, we found a correlation between the pA
site changes induced by differentiation or by TDP-43 knockdown
(KD) in undifferentiated hESCs (Pearson’s correlation coefficient
(r) = 0.62; Figure 4A; Table S5). This indicates that the decreased
activity of TDP-43 upon early differentiation is a major cause of
differentiation-induced APA.
To systematically identify the primary RNA motifs that
contribute to the regulation of APA, we analyzed the enriched
sequence motifs. We identified GU-rich motifs as the highest-
ranking sequences that are enriched around the pA sites that
changed during hESC differentiation (Figure S4A). Notably,
similar motifs were enriched around differential pA sites affected
by KD of TDP-43 in undifferentiated hESCs and by cTdp-43 KO
in mESCs (Figure S4A). Moreover, RNA maps of these motifs
showed that they are located in the region upstream of the regu-
lated pA sites (Figures S4B–S4D), where accessory regulatory
sites typically reside (Di Giammartino et al., 2011). The similar
pattern of motif enrichment for all conditions (Figure S4A) and
the high correlation in processing changes upon differentiation
or TDP-43 KD (Figure 4A) indicated that binding of TDP-43 close
to the regulated pA sites could explain a large portion of the
global changes in APA that take place upon differentiation of
hESCs or mESCs.
To validate the direct binding of TDP-43 to the regulated pA
sites, we conducted individual nucleotide-resolution UV cross-
linking and immunoprecipitation (iCLIP) experiments with TDP-
43 in hESCs (Ko¨nig et al., 2010). A direct role of TDP-43 in APA
regulation was evident by the clear position-dependent dual
enrichment of its binding sites around the pA sites that undergo
Figure 2. NEAT1_2 Recruits TDP-43 into Paraspeckles
(A) A schematic overview of the mRNA-interactome analysis strategy used for identifying relocalized RBPs upon paraspeckle formation. Peptides were identified
by UV crosslinking and capturing mRNA-RBP complexes using Oligod(T)25-bound magnetic beads followed by mass spectrometry. Because deletion of the
NEAT1 pA site promotes paraspeckle formation in undifferentiated hESCs (Figure 1), comparing peptide counts in NEAT1DpA with WT cells detects resulting
changes in mRNA-RBP occupancy. Further details regarding global mRNA-interactome analysis are given in Figures S2D–S2F.
(B) A Volcano plot displaying fold changes of mRNA-bound RBPs in NEAT1DpA undifferentiated hESCs and their respective statistical score (t test, n = 3
biological replicates per condition). Previously identified paraspeckle proteins are labeled red.
(C) Western blot analysis of TDP-43 and non-paraspeckle control RBPs of the lysate versus the supernatant fraction after mRNA depletion by Oligod(T) capture,
from UV-crosslinked WT and NEAT1DpA undifferentiated hESCs. Right: quantification (t test, n = 3, **p < 0.01).
(D) The positions of TDP-43 cross-linked sites (red bars) in NEAT1 that were identified by TDP-43 iCLIP (from Tollervey et al., 2011). The 12-kb deleted regions
(black boxes) in the NEAT1DUG cell line, and the positions of the three longest stretches of UG repeats within the transcript (yellow bars) are indicated.
(E–G) Representative maximum projection photomicrographs from RNA-FISH and immunofluorescence of NEAT1_2 and the paraspeckle markers PSPC1 (E)
and TDP-43 (F) in WT and NEAT1DUG HAP-1 cells. Blue, DAPI (nuclear stain). Scale bars, 10 mm. (G) shows quantification of the TDP-43 immunofluorescence
signal in DAPI and NEAT1 segmented areas corresponding to nuclei and paraspeckles, respectively. More than 200 cells were analyzed per group; Mann-
Whitney U test, ***p < 0.0001. The threshold was set on a ratio of TDP-43/NEAT1 signal as described in the STAR Methods.
(H) Diagram of NEAT1 corresponding to (C), with the position of an ectopic stretch of 60 UG repeats.
(I and J) Representative maximum projection photomicrographs from NEAT1 RNA-FISH and TDP-43 immunofluorescence (I) and analysis of co-localization (J).
Cell lines included WT, NEAT1DUG, and NEAT1DUG+UG60 HAP1 cells. Cell numbers and statistical analysis were as in (F). Scale bars, 10 mm.
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Figure 3. TDP-43 Maintains Pluripotency and Enhances Somatic Cell Reprogramming
(A) Volcano plot displaying gene expression fold changes and their respective statistical score (adjusted p value, Fisher’s exact test), comparing untreated and
tamoxifen-treated cTdp-43 KO undifferentiated mESCs (n = 10 biological replicates per condition). Known pluripotency and trophectoderm markers are labeled
red and blue, respectively (marked factors fulfilled p < 0.01).
(legend continued on next page)
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APA following TDP-43 KD or KO, as evident by the RNA map
showing the density of its crosslinking in hESCs (Figures S5A–
S5E) or of GU-rich motifs (Figures S5F and S5G), consistent
with the previously reported RNA map in HEK293 cells (Rot
et al., 2017). Enriched binding of TDP-43 was detected close
to repressed pA sites (within 100 nt) and further upstream and
downstream of enhanced sites (Figure S5F) in a pattern that
was also conserved in mESCs (Figure S5G). Notably, TDP-43-
dependent regulation of over 40% of the affected pA sites was
conserved between hESCs and mESCs (Table S5). These ana-
lyses validated the high quality and positional precision of our
data and identified the RNA targets that are directly regulated
by TDP-43 according to position-dependent principles.
Notably, transcripts exhibiting APA upon cTdp-43 KO were
significantly enriched for the GO-term ‘‘stem cell maintenance’’
(Figure 4B; Table S5). Moreover, TDP-43 dictated the APA
pattern of the core naive pluripotency network, including Sox2,
Nr5a2, Esrrb, Klf2, Tfcp2l1, Tbx3, Zfp281, Tcf7l1, Zic3, and
Tdgf1 (Kalkan et al., 2017), which all changed in the same direc-
tion as upon early differentiation (Figure 4C; Figure S3F). One of
the conserved APA events was evident in the mRNA encoding
the pioneer pluripotency transcription factor Sox2. This gene en-
codes a 30 UTR harboring two pA sites, and the transcripts
showed a proximal-to-distal shift upon TDP-43 KD in hESCs
and cTdp-43 KO in mESCs and upon hESC differentiation (Fig-
ure 4D; Table S5). The TDP-43 crosslinking pattern on the
Sox2 transcript in undifferentiated mESCs, in the 100-nt region
adjacent to the distal pA site and between 100–200 nt from the
proximal site (Figure 4E), is in agreement with the mode of regu-
lation observed by the RNA map analysis (Figure S5G). Further-
more, TDP-43 expression correlated with the abundance of
SOX2 protein, which dramatically declined following cTdp-43
KO in mESCs (Figure 4F).
To understand how TDP-43 promotes SOX2 expression, we
created a minigene reporter containing the 30 UTR of SOX2
located downstream of EGFP (Figure 4G). Flow cytometry
showed that overexpression of TDP-43 in HEK293T cells
increased the GFP signal in the presence ofmiR-21, which could
target the long isoform of SOX2 (Figure 4H). Mutating the prox-
imal pA site in the SOX2 30 UTR made it insensitive to TDP-43,
confirming that TDP-43 regulates SOX2 expression through
APA (Figure 4I). Finally, mutating the miR-21 binding site in the
reporter construct, which resides in the long isoform, ablated
the effect of TDP-43 on EGFP expression (Figure 4J). Impor-
tantly, upregulation of miR-21 took place upon primitive streak
differentiation (Figure 4K), which agrees with the finding that
deletion of its binding site in Sox2 by genome editing led to a
dramatic induction of Sox2 in primitive streak progenitors
(Figure 4L). These results show that TDP-43 promotes pluripo-
tency by APA-mediated regulation of pluripotency factors,
including Sox2.
TDP-43 Represses Formation of Paraspeckles by
Regulating APA of NEAT1
Beyond direct regulation of pluripotency genes via APA, we
sought to understand how TDP-43 regulates paraspeckle for-
mation via APA of NEAT1. Given that the NEAT1 isoform
switch takes place upon differentiation and KD of TDP-43
(Figure 1), we speculated that downregulation of TDP-43
coincides with and, therefore, contributes to the isoform
switch during differentiation. Indeed, decreased expression
of TDP-43 was evident in a published RNA-seq dataset of
hESCs differentiated into developmental progenitors (Gifford
et al., 2013), which was inverse to the upregulation of
NEAT1_2 (Figure 5A). Moreover, we observed significantly
lower levels of TDP-43 transcript and protein upon 3 days of
differentiation (Figures 5B and 5C; Figure S5H). Similarly, the
expression of NEAT1 was inversely correlated with pluripo-
tency genes and TDP-43 during the reprogramming of human
fibroblasts to iPSCs (Figure S5I).
To decipher whether TDP-43 directly regulates NEAT1 pro-
cessing, we analyzed the RNA-binding profile of TDP-43 by
iCLIP (Figures S5A–S5G). This showed that TDP-43 binds to
evolutionarily conserved clusters of GU-rich motifs upstream of
the pA signal in mESCs (Figure 5D). This pattern agrees with
the enhancing effect of TDP-43 when binding more than
100 bp upstream of the pA site in Sox2 (Figure 4E). To validate
the direct effect, we used CRISPR-Cas9 editing of mESCs
to excise a 100-nt GU-rich binding site of TDP-43 that is
located 105 nt upstream of the internal Neat1 pA site (Fig-
ure 5E; Neat1D100nt mESCs). Importantly, undifferentiated
Neat1D100nt mESCs exhibited high expression of the Neat1_2
isoform (Figure 5F) and paraspeckles (Figure 5G), which were
induced to a comparable amount as in cTdp-43 KO orNeat1DpA
mESCs. Moreover, we removed growth factors promoting
pluripotency from Neat1D100nt and control mESC cultures to
induce paraspeckles while also ectopically expressing iTDP-
43-EGFP. The capacity of TDP-43-EGFP to repress the
expression of Neat1_2 under these conditions was reduced
2-fold in Neat1D100nt cells (Figure S5J). Finally, Neat1D100nt
mESCs exhibited an increased differentiation propensity, as
evident by the decline of NANOG during spontaneous differen-
tiation (Figure S5K). We concluded that TDP-43 binding
upstream of the Neat1 pA site enhances the production of
(B) Representative photomicrographs of untreated cTdp-43 KO mESCs, following tamoxifen treatment in 2iLIF medium and following 2-day spontaneous
differentiation.
(C and D) Representative flow cytometry analyses of spontaneously differentiating (2 days) iTDP-43-EGFP mESCs that were treated with doxycycline (over-
expression [OE]) or left untreated and immunostained for SSEA-1 (C) and NANOG (D). Non-treated cells were used for immunoglobulin G (IgG) control staining.
The mean of three independent experiments is depicted on the right (error bars, SD); two-sided t test, ***p < 0.001.
(E–I) Reprogramming of hiF-T secondary fibroblasts with or without (empty vector) transduction of TDP-43, cells harboring doxycycline-inducible reprogramming
factors (Cacchiarelli et al., 2015) (E), number of alkaline phosphatase (AP)-positive human induced pluripotent stem cell (hiPSC) colonies emerging on day 10 and
14 of reprogramming (F and G; dots represent replicates from three independent experiments, Mann-Whitney U test, ***p < 0.001), representative photomi-
crographs (H), and TRA-1-60 flow cytometry analysis (I); n = 3 independent experiments, gating was based on an IgG control.
(J and K) Reprogramming of primary human fibroblasts (J) and the number of AP-positive colonies on day 30 (dots represent replicates from three independent
experiments) with or without (empty vector) transfection of TDP-43 (K); statistical analysis as in (F) and (G).
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Figure 4. TDP-43 Regulates APA of Genes Important for Pluripotency, Including Sox2
(A) Scatterplot displaying relative changes of pA sites upon differentiation of hESCs (Figures S3A and S3B) and changes accruing by knocking down TDP-43 in
undifferentiated hESCs for 48 h (n = 4 control short hairpin [shCTRL] and n = 8 shTDP-43 using 2 TDP-43-targeting short hairpin RNAs [shRNAs] with 4 replicates
for each; adjusted p < 0.05, Fisher’s exact test). Linear regression (gray line) and the 90% confidence interval region (light blue) are shown (Pearson’s correlation
(legend continued on next page)
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polyadenylated Neat1_1, which decreases the production of
Neat1_2 and assembly of paraspeckles upon differentiation.
Neat1_2 Is Required for Efficient Early Differentiation by
Cross-Regulation with TDP-43
To analyze whether Neat1 functionally regulates the differenti-
ation of ESCs, we excised the triple helix (TH) region at the
30 end of the gene, which is required for stabilizing Neat1_2
in somatic cells (Wilusz et al., 2012; Yamazaki et al., 2018).
Homozygous TH deletions in mESCs significantly reduced
the number of paraspeckles in differentiated cells (Figure 6A;
Figure S6A). Notably, the in vitro pluripotency phenotype
of Neat1DTH mESCs was significantly prolonged during
differentiation, as evident by higher expression of the pluripo-
tency markers SSEA-1 and NANOG (Figures 6B and 6C),
mimicking the phenotype of TDP-43 overexpression (Figures
3C and 3D).
To further assess the function of Neat1_2 during embryonic
development, we used tetraploid (4n) mouse embryo 4 2n
mESC aggregations for generating chimera embryos exclusively
derived from mESCs, whereas extra-embryonic lineages were
derived from the 4n cells (Figure 6D; Eakin and Hadjantonakis,
2006). We aggregated 4n membrane-targeted, tdTomato-ex-
pressing, 2- to 4-cell-stage embryos with wild-type (WT),
Neat1DpA, or Neat1DTH mESCs, which we generated by
editing IDG3.2 mESCs, a line that is routinely used for gener-
ating full-term chimeras (Engert et al., 2013). Embryonic day
7.75 (E7.75) to E8.0 embryos derived from Neat1DTH mESCs
were abnormal and exhibited defective patterning of axial meso-
derm and the node, as indicated by scattered expression of
FOXA2 and BRACHYURY (Figures 6E and 6F; Figures S6B
and S6C). Scattered expression of FOXA2 also suggested that
the identity of definitive and visceral endoderm was perturbed
(Figure S6C).
In contrast, we did not observemorphological abnormalities of
chimera embryos derived fromNeat1DpA orWTmESCs (Figures
6E and 6F; Figures S6D and S6E), which efficiently form para-
speckles (Figure 1D). We also looked for phenotypic effects of
inducing NEAT1_2 in undifferentiated, pluripotent NEAT1DpA
hESCs. Comparison with the parental cells showed that a cohort
of mesoderm and endoderm markers were already expressed in
the undifferentiated state, plausibly in subpopulations, despite
the cells being maintained in pluripotency conditions (Fig-
ure S6F). Taken together, these results demonstrate that para-
speckle formation facilitates the differentiation of pluripotent
cells and embryonic patterning.
Last, we analyzed the interdependence of TDP-43 and
Neat1_2 in the regulation of early spontaneous differentiation.
We manipulated the two factors concomitantly by deleting the
endogenous TH region in Neat1_2 in the cTdp-43 KO mESC
line. Paraspeckles are normally increased upon inducible KO
of Tdp-43 by tamoxifen treatment of cTdp-43 KO mESCs (Fig-
ure 1E), whereas Neat1DTH mESCs are defective in the induc-
tion of paraspeckles (Figure 6A; Figure S6A). We assessed
whether deficient induction of paraspeckles upon tamoxifen
treatment of the cTdp-43 KO Neat1DTH mESCs affects any
of the cellular responses to TDP-43 depletion. Indeed, the
key pluripotency proteins SOX2 and NANOG were downregu-
lated to a lesser extent upon spontaneous differentiation and
tamoxifen treatment of cTdp-43 KO Neat1DTH mESCs with
deficient paraspeckle induction compared with cTdp-43KO
mESCs Figures 6G–6J). Global transcriptome analysis re-
vealed the same trend, evident by maintained expression of
pluripotency genes and reduced expression of early differenti-
ation genes, including Cdx2 and Brachyury (Figure 6K; Table
S6). This was supported by the higher proliferative capacity
of tamoxifen-treated differentiating cTdp-43 KO Neat1DTH
mESCs compared with Neat1 WT mESCs (Figure 6L). Strik-
ingly, we observed a dramatic reduction in the number
of APA-regulated genes in tamoxifen-treated cTdp-43KO
Neat1DTH mESCs as compared with control cells where in-
duction of cTdp-43KO induces paraspeckles (Figure 6M;
Table S6). Thus, decreased abundance of TDP-43 promotes
dissolution of pluripotency largely through APA regulation,
but induction of Neat1_2 is required for efficient APA regula-
tion. Collectively, we conclude that cross-regulation between
Neat1 and TDP-43 is essential for their efficient reciprocal
roles in the pluripotency-differentiation transition.
coefficient [r] = 0.62). Increased use of the proximal pA site has positive values, and decreased use has negative values, based on genes passing filtering and
statistical analysis as outlined in Figures S3C–S3E.
(B and C) Non-redundant Gene Ontology (GO) terms (B) and ground-state and general pluripotency factors (C), characterized by (Kalkan et al., 2017), of genes
exhibiting APA upon cTdp-43 KO in mESCs (n = 10 independent sample replicates per group; genes passing filtering and statistical analysis as outlined in
Figure S3C–S3E).
(D) Representative diagrams displaying the transcript isoforms ofSox2 upon cTdp-43 KO inmESCs and frequencies of the pA sites inSox2 andSOX2 upon cTdp-
43 KO in mESCs or KD of TDP-43 and 72 h CHIR99021 treatment of hESCs; samples as above.
(E) The positions of TDP-43 crosslinking (red bars) in Sox2 transcript from mESCs, as defined by iCLIP, surrounding the proximal and distal pA sites; n = 2
biological replicates (Figure S5C) combined into a single track.
(F) Western blot analysis of SOX2, TDP-43, and histone H3 following tamoxifen treatment (3 days) of cTdp-43 KO mESCs; independent replicates are shown.
(G) An illustration of the EGFP-SOX2 30 UTR reporter minigene displaying endogenous positions of the proximal and distal pA sites and the miR-21
binding site.
(H–J) Representative flow cytometry analyses of HEK293T cells with the doxycycline-inducible TDP-43 gene cassette co-transfected with miR-21
(transfected cells were gated using tdTomato as described in STAR Methods), and the respective EGFP-SOX2 30 UTR constructs: unmodified (H),
harboring deletion of the proximal pA site (I), or with deletion of the miR-21 binding site (J). Control (CTR) indicates cells that were not treated with
doxycycline.
(K) Boxplot depicting relative levels ofmiR-21 in undifferentiatedmESCs and in primitive streak (PS)-like progenitors generated by 3 dCHIR99021 treatment (n = 6
independent replicates, two sided t test; p value ***% 0.001).
(L) Boxplot analyses depicting levels of the Sox2 transcript in WT mESCs and cells lacking the endogenous miR-21 binding site in Sox2 (Sox2DmiR21) under
pluripotency conditions (top) and upon PS differentiation (bottom) (n = 5 and 6 independent replicates, two-sided t test; *p% 0.01).
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DISCUSSION
Network modules that promote efficient cell state tran-
sitions are inherent to differentiation, regulation of organ-
ismal development, homeostasis, and regeneration (Alon,
2007). Cross-regulation between regulatory factors can
promote lineage bifurcation and has been associated with
transcription factors, microRNAs, and signaling cascades
F
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Figure 5. TDP-43 Directly Promotes Neat1
Polyadenylation to Repress Paraspeckles
in Pluripotent Cells
(A) Normalized expression of TDP-43 and NEAT1
in undifferentiated hESCs and differentiated
developmental progenitors (transcriptome data
from Gifford et al., 2013).
(B and C) Quantification of TDP-43 during hESC
differentiation, the transcript (B) based on Fig-
ure 1C, and on western blotting (C) using histone
H3 for normalization (representative blot in Fig-
ure S5H). Samples were derived from undifferen-
tiated hESCs and cells differentiated toward
mesoderm progenitors using CHIR99021; (B)
Fisher’s exact test and n = 2 and (C) t test, n = 3
independent replicates, as indicated by dots; error
bars, SD; *p% 0.05, ***p% 0.001).
(D) TDP-43 crosslinked positions (red bars) in the
Neat1 transcript (shown are Neat1_1 and the 50
region of Neat1_2) from mESCs analyzed by iCLIP
(replicates and samples as in Figure 4E). Sequence
conservation score is plotted as gray bars (n.c., not
conserved).
(E) Modified mESC lines lacking the endoge-
nous binding site of TDP-43 upstream of the pA
site (Neat1D100nt) or lacking the pA signal
(Neat1DpA). The region deleted in the Neat1D100
mESC line is highlighted and enlarged, showing
the GU-rich motifs and the TDP-43 crosslinking
positions in the region (based on D).
(F and G) Percentage of cells exhibiting Neat1_1 or
Neat1_2 foci (F) and number of paraspeckles in
undifferentiated mESCs lines (G) and parental WT,
Neat1D100nt, cTdp-43 KO mESC line 2 days
following tamoxifen treatment and Neat1DpA (cell
numbers analyzed, replicates, and statistical
analysis as in Figure 1B).
(Alon, 2007; Enver et al., 2009; Rybak
et al., 2008). We show here that cross-
regulation between paraspeckles and
TDP-43 is similarly essential for their
efficient roles in promoting transition
between pluripotent and differenti-
ated cell fates. TDP-43 inhibits differ-
entiation of ESCs, and lowers the bar-
rier for somatic cell reprogramming,
but its abundance decreases during
exit from pluripotency, which changes
APA of hundreds of genes, including
the lncRNA Neat1 to induce the
Neat1_2 isoform. As a result, TDP-43
is recruited into paraspeckles, which
partially sequester it away from mRNAs, further decreasing
the activity of TDP-43 in regulating APA during early differen-
tiation. Induction of Neat1_2 is essential for efficient early
differentiation of ESCs and embryonic patterning during
gastrulation. Thus, cross-regulation between TDP-43 and par-
aspeckles is reflected in the reciprocal biological functions of
these two factors in promoting either the pluripotent state or
differentiation of ESCs.
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Changes in APA have been observed previously during differ-
entiation processes that include myogenesis, adipogenesis, and
embryogenesis (Di Giammartino et al., 2011; Hoque et al., 2013).
Moreover, the core elements of the cleavage and polyadenyla-
tion complex, FIP1 (Lackford et al., 2014) and NUDT21 (Brum-
baugh et al., 2018) have been implicated in the regulation of
APA during ESC differentiation. Here we used iCLIP and motif
analysis to show how TDP-43 regulates APA of specific tran-
scripts through binding to RNA motifs around the regulated pA
sites (Figures S4 and S5). Therefore, TDP-43 has a conserved
role in promoting the production of short Sox2 transcript, which
is required for efficient expression of this pluripotency and re-
programming factor. It also promotes the short isoform of
Neat1_1, which suppresses paraspeckle formation. This role of
TDP-43 in early cell fate transitions is in line with the past obser-
vation that it is essential for murine development (Sephton
et al., 2010).
When the pendulum swings in the direction of differentiation,
the abundance of TDP-43 decreases to a level permissive for
an isoform switch in NEAT1, resulting in the production of
NEAT1_2 that scaffolds paraspeckles. It has been shown pre-
viously that efficient interaction of TDP-43 and several other
RBPs with NEAT1_2 occurs as a result of phase separation
into paraspeckles (Maharana et al., 2018; Yamazaki et al.,
2018). Here we have shown that induction of NEAT1_2 in
ESCs partly sequesters TDP-43 and other paraspeckle RBPs
away from mRNAs, most likely because of their recruitment
into the paraspeckle compartment. This sequestration could
contribute to the decreased activity of TDP-43 upon early dif-
ferentiation, facilitating the global shift in APA and, therefore,
exit from pluripotency, which could partly explain how
Neat1_2 promotes early differentiation. It is likely that Neat1
also acts through additional mechanisms, such as the recently
reported role of NEAT1_2 in scaffolding microprocessor and
other RBPs into paraspeckles to regulate microRNA biogenesis
(Jiang et al., 2017), and Neat1_1 on its own could form ‘‘micro-
speckles,’’ whose functions are currently unknown (Li et al.,
2017). Thus, our study indicates that formation of a membrane-
less compartment can be regulated through the processing of
its RNA scaffold to coordinate a specific developmental
transition.
We have characterized developmental phenotypes of embry-
onic cells lacking the TH of Neat1, which have a reduced num-
ber of paraspeckles because of destabilized Neat1_2. We used
the tetraploid complementation approach, which normally
generates viable embryos from ESCs and is used to investigate
the role of factors of interest in embryonic tissues (Eakin and
Hadjantonakis, 2006). This method enables classifications of
embryonic versus extraembryonic phenotypes by circumvent-
ing pre-blastocyst developmental arrest, which has been
observed upon depletion of Neat1_2 in a recent study (Hupa-
lowska et al., 2018). Tetraploid complemented embryos derived
from Neat1DTH mESCs have inefficient patterning during
gastrulation. Notably, we observed elevated expression of the
transcription factor Cdx2 as the major change that distin-
guishes the response of Neat1DTH and WT mESCs to loss of
TDP-43 (Figure 6K), which agrees with the previously observed
role of Neat1 in regulating Cdx2 (Hupalowska et al., 2018). The
findings of both studies are also consistent with previous
studies that observed decreased litter size, aberrant mammary
gland morphogenesis, and smaller pups (Nakagawa et al.,
2014; Standaert et al., 2014) in Neat1 KO mice, which lack
paraspeckles (Nakagawa et al., 2011). This phenotype of
Neat1 KO mice is surprisingly mild, given the apparent pheno-
types observed in the study, which indicates that the function of
Neat1 might be compensated by additional factors that assist
cell fate transitions during in vivo murine development.
Beyond the mechanisms of early development, our findings
are likely also relevant also for other types of cell fate transitions
because both TDP-43 and NEAT1 are broadly expressed (Shel-
kovnikova et al., 2018). Moreover, amyotrophic lateral sclerosis
(ALS)-causing mutations in TDP-43 affect its phase separation
Figure 6. Efficient Dissolution of Pluripotency upon Depletion of TDP-43 Requires Paraspeckles
(A) Representative photomicrographs demonstrating the downregulation of Neat1_2 paraspeckles in spontaneously differentiating mESCs by deletion of the
triple helix (DTH) in the 30 region (further results in Figure S6A). Red, Neat1_1 and_2 probes; blue, DAPI (nuclear stain). Scale bars, 10 mm.
(B and C) Pluripotency assessment by SSEA-1 (B, right, quantified gated positive cells) and intracellular NANOG (C) flow cytometry of spontaneously differ-
entiating Neat1DTH and WT mESCs (duration indicated). IgG-treated samples were used for gating positive cells (red line in B). Error bars, SD; two-sided t test;
biological replicates, n = 3 per time point; *p < 0.05, **p < 0.01.
(D–F) In vivo analysis of the developmental potency of mESCs exhibiting downregulation of paraspeckles using a 2n mESC - 4n aggregated mouse embryo
complementation assay, giving rise, respectively and exclusively, to embryonic and extraembryonic tissues (D). Shown are mouse embryos (E7.75–E8.0) re-
sulting from aggregations ofNeat1DTH andNeat1DpAmESCs with 4n 2- to 4-cell-stage embryos and representative analysis of FOXA2 (E) and BRACHYURY (F)
by immunostaining (n = 7 forNeat1DTH [5 are shown in Figures S6B and S6C], n = 7 forNeat1DpA [2 are shown in Figure S6D], and n = 3 for parental control mESC
[2 are shown in Figure S6E]). Non-manipulated embryos are shown on the right. Blue, DAPI (nuclear stain). Scale bars, 100 mm. A, anterior; P, posterior;
p, proximal; d, distal.
(G–L) Pluripotency assessment by intracellular immunostaining flow cytometry (G–J; error bars, SD, two-sided t test in I, n = 3), RNA-seq (K; n = 3/group, Fisher’s
exact test), and growth kinetics (L; Mann-Whitney U test, n R 8/group as indicated by dots) in differentiating parental cTdp-43 KO mESCs or the same line
harboringNeat1DTH, treated with tamoxifen during 2.5 days of spontaneous differentiation or left untreated (all consisting of independent replicates). Also shown
are representative flow cytometry plots of SOX2 (G) and quantification of gated positive cells according to the IgG control (H) and of NANOG (I and J). IgG-treated
sampleswere used to gate the positive cells (dotted red line) and to quantify the enrichment of these cells. In (K), shown are up- and downregulated representative
differentiation and pluripotency genes according to the ScoreCard panel (Tsankov et al., 2015, and Kalkan et al., 2017, respectively), comparing the impact of
Tdp-43 KO inmESCs lackingNeat1_2 (Neat1DTH) with control mESCs harboringWTNeat1. In (L), the width of colored intervals represents the interquartile range
of the growth kinetics measurements.
(M) Histogramdepicting rearrangements (direction and degree) of pA sites following cTdp-43 KO inNeat1DTHmESCs comparedwith the respective parental WT
cells (genes passing filtering and statistical analysis as outlined in Figures S3C–S3E; APA in the range of ±5-fold change, p < 0.01). mESCs were treated with
tamoxifen for 2.5 days or left untreated during spontaneous differentiation (n = 3 independent replicates/group).
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properties (Conicella et al., 2016), which could affect its localiza-
tion into paraspeckles (Yamazaki et al., 2018). Moreover,
increased formation of paraspeckles has been observed in mo-
tor neurons of patients with ALS (Nishimoto et al., 2013). There-
fore, cross-regulation of TDP-43 andNEAT1 could play a role not
just in development but also in diseases such as ALS and cancer,
where abnormal RNA granules involving TDP-43 and NEAT1 are
a common feature (Adriaens et al., 2016; Hennig et al., 2015;
Nishimoto et al., 2013; Tollervey et al., 2011).
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Sox2 monoclonal antibody (D6D9) Alexa
647-conjugated
Cell Signaling Cat no. 5067; RRID: AB_10828229
Sox2 monoclonal Antibody Cell Signaling Cat no. 2748S; RRID: 823640
Nanog monoclonal Antibody Cell Signaling Cat no. 8822; RRID: AB_11217637
TDP-43 polyclonal Antibody Sigma-Aldrich Cat no. SAB4200006; RRID: AB_10610848
TDP-43 polyclonal Antibody Proteintech Group Cat no. 10782-2-AP; RRID: AB_615042
GFP polyclonal Antibody Molecular Probes/Thermo Fisher Cat no. A6455; RRID: AB_221570
SFPQ monoclonal Antibody Thermo Fisher Scientific Cat no. MA1-25325; RRID: AB_2186931
NONO polyclonal Antibody Abcam Cat no. ab70335; RRID: AB_1269576
CPEB1 polyclonal Antibody Cell Signaling Cat no. 13583
PSPC1 rabbit polyclonal antibody Naganuma et al., 2012
SRSF3 polyclonal antibody ProteinTech Group Cat no. 10916-1-AP; RRID: AB_2185064
TNPO1 monoclonal antibody Abcam Cat no. ab10303; RRID: AB_2206878
U2AF2 monoclonal antibody Sigma-Aldrich Cat no. U4758; RRID: AB_262122
Brachyury N-19 goat polyclonal antibody Santa Cruz Biotechnologies Cat no. sc17743; RRID: AB_634980
Foxa2 (HNF-3b) M-20 goat polyclonal Santa Cruz Biotechnologies Cat no. sc-6554; RRID: AB_2262810
RFP rabbit polyclonal Rockland Cat no. 600-401-379S; RRID: AB_2209751
Donkey anti-rabbit IgG 555 Invitrogen Cat no. A31572; RRID: AB_162543
Donkey anti-goat IgG 488 Invitrogen Cat no. A11055; RRID: AB_2534102
Histone H3 polyclonal Antibody Abcam Cat no. ab1791; RRID: AB_302613
Beta Actin polyclonal Antibody New England Biolabs/Cell
Signaling antibody
Cat no. 8H10D10; RRID: AB_2242334
RNAPolII-S5,S2 Abcam Cat no. ab103968; RRID: AB_2687918
DyLight 650-conjugated anti SSEA-1 (clone MC-480) Thermo Fisher Cat no. MA1-022-D650; RRID: AB_2536696
Alexa Fluor 647-conjugated anti TRA-1-60 BD Bioscience Cat no. 560122; RRID: AB_1645448
Alexa Fluor 647 Dk anti-Gt IgG (H+L) Thermo Fisher Cat no. A11058; RRID: AB_2534105
Goat anti-rabbit IgM-HRP Santa Cruz Biotechnology Cat no. sc-2030; RRID: AB_631747
Goat anti-mouse IgG HRP-conjugated Dianova Cat no. 115-035-003; RRID: AB_10015289
Chemicals, Peptides, and Recombinant Proteins
(Z)-4-Hydroxytamoxifen Sigma-Aldrich H7904
Neurobasal Medium Thermo Fisher 21103049
DMEM F12 Thermo Fisher 11320033
N2 Thermo Fisher 17502048
B27 Thermo Fisher 17504044
Glutamax Thermo Fisher 35050
1% nonessential amino acids Thermo Fisher 1140050
2-mercaptoethanol Thermo Fisher 31350-010
MEK inhibitor PD0325901 Axon Medchem 1408
GSK3 inhibitor CHIR99021 Tocris 4953/50
LIF produced in house SV30160.03HI
Trypsin-EDTA Thermo Fisher 25200056
HyClone Fetal Bovine Serum (FBS) GE Healthcare SV30160.03HI
mTeSR1 medium Stem Cell Technologies 058-50
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Matrigel Cornig 356234
Gentle Cell Dissociation Reagent StemCell Technologies 7174
KnockOut Serum Replacement Thermo Fisher 10828028
DMEM high glucose Thermo Fisher 11965092
Blue Sepharose 6 Fast Flow/ HisTrap HP columns GE LifeSciences 17-0412-01
recombinant WNT3A D. Ten Berge N/A
Retinoic Acid R2625-50MG Sigma
recombinant BMP4 R&D systems 314-BP
Accutase Sigma-Aldrich A6964
Y-27632 ROCK inhibitor R&D systems 1254/10
RPMI1640 Thermo Fisher 11875093
L-Glutamine Thermo Fisher 25030081
B27 supplement without insulin Thermo Fisher A1895601
Lipofectamine 3000 Thermo Fisher L3000008
Lipofectamine RNAiMAX Thermo Fisher 13778150
Puromycin Sigma-Aldrich P8833-10MG,
blasticidine Invivogen ant-bl-05
G418 Invivogen ant-gn-01
Trizol LS Life Technologies 10296028
QIAzol QIAGEN 79306
Zymo Direct-zol Zymogen R2052
RNeasy Mini Kit QIAGEN 74104
SuperScript III Reverse Transcriptase Thermo Fisher 18080085
RNase H, recombinant New England Biolabs M0297S
miRNeasy Micro Kit QIAGEN 217084
KOD FX Neo enzyme Toyobo KFX-201
Taqman assay master mixl Thermo Fisher 4369514
Q5 High-Fidelity 2X Master Mix Thermo Fisher M0492
miScript PCR Starter Kit QIAGEN 218193
formamide Calbiochem 4610-OP
Dextran Sulfate VWR 9011-18-1
competitor tRNA from E.coli Roche Diagnostics 10109541001
methanol-free formaldehyde Thermo Fisher 28906
digoxigenin (DIG) RNA labeling kit Roche 11175025910
2-well m-Slides Ibidi 80286
8-chambr Slides Ibidi 80826
DAPI New England Biolabs 9071S
SYTOX Blue Dead Cell Stain, for flow cytometry Thermo Fisher S34857
UltraPure BSA Thermo Fisher AM2616
vanadyl-ribonucleoside complex New England Biolabs S1402S
Insulin (human recombinant - yeast) Life Tech 12585-014
Transferrin (human recombinant) Sigma-Aldrich T3705-1G
Sodium selenite Sigma-Aldrich S5261-10G
Ascorbic acid 2-phosphate Sigma-Aldrich A8960-5G
FGF2 (human recombinant - E. coli) Peprotech 100-18B (1 mg)
TGFB (human recombinant - E. coli) Peprotech 100-21 (100 ug)
TURBO Dnase Thermo Fisher am2238
RNeasy MinElute RNA cleanup QIAGEN 74204
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protease inhibitors Merck Millipore 539134
phosphatase inhibitors Sigma-Aldrich 4906837001
proteasome inhibitor Sigma -Aldrich MG132
Mini-PROTEAN TGX Stain Free Gels, 4-15% Bio-Rad Laboratories 456-8086
Clarity Western ECL Substrate Bio-Rad Laboratories 170-5060
5% milk powder Carl Roth T145.1
RNasin Plus RNase inhibitor Promega PRN2615
Lys-C Wako Chemicals 125-02543
Trypsin Promega V5111
Igepal CA-630 Sigma-Aldrich I8896
Triton X-100 Sigma-Aldrich 9002-93-1
Protein A Dynabeads Thermo Fisher 10002D
RNase I Ambion AM2295
RNase A Nacalai Tesque 9001-99-4
Proteus Clarification Mini Spin Column Generon GEN-MSF500
ssRNA ligase New England Biolabs M0204S
PEG400 Sigma-Aldrich 202398
sodium butyrate Sigma-Aldrich B5887-250MG
ascorbic acid Sigma-Aldrich A8960
Hydrocortisone Sigma-Aldrich H0396
Insulin Thermo Fisher 12585014
Protan BA85 Nitrocellulose Membrane Thermo Fisher LC2009
proteinase K Roche 3115828001
Phase Lock Gel Heavy tube 713-2536 VWR
Glycoblue coprecipitant Ambion 9516
Costar SpinX column Corning Incorporated 8161
CircLigase ssDNA Epicenter CL4111K
Accuprime Supermix 1 Thermo Fisher Accuprime Supermix 1
Agencourt AMPure XP beads Beckman-Coulter Agencourt AMPure XP beads
Critical Commercial Assays
P3 Primary Cell 4D-Nucleofector Kit Lonza V4XP-3012
Nucleofector Kit V Lonza VCA-1003
RiboZero Epicenter Cat# MRZG12324
TruSeq stranded total RNA Sample Prep Kit Illumina Cat# 20020599
QuantSeq mRNA 30 end sequencing kit Lexogen Cat# SKU 015.96 and SKU 016.96
alkaline phosphatase staining Sigma-Aldrich AB0300-1KT
Agilent 2100 Bioanalyzer with RNA Pico 6000 kit Agilent 5067-1513
Qubit dsDNA HS Assay Kit Thermo Fisher Q32854
Inside Stain kit Miltenyi Biotech 130-090-477
Nucleofector MEF 1 Kit Lonza VPD-1004
Nascent RNA Capture Kit Thermo Fisher C10365
Deposited Data
QuantSeq and RNaseq libraries to study
developmental alternative polyadenylation in hESC,
its progeny and upon TDP-43 KD
This paper E-MTAB-5090. Accessible via https://www.
ebi.ac.uk/arrayexpress/
RNaseq libraries to study developmental alternative
polyadenylation in human primitive streak
progenitors derived from hESCs.
This paper E-MTAB-5099. Accessible via https://www.
ebi.ac.uk/arrayexpress/
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QuantSeq libraries to study TDP-43 dependent
alternative polyadenylation in mESCs and upon
paraspeckles/TDP43 perturbations
This paper E-MTAB-5091. Accessible via https://www.
ebi.ac.uk/arrayexpress/
RNaseq libraries to study TDP-43 dependent
alternative polyadenylation in mESCa and cTdp43KO
This paper E-MTAB-5097. Accessible via https://www.
ebi.ac.uk/arrayexpress/
iCLIP datasets for TDP-43 This paper E-MTAB-5100. Accessible via https://www.
ebi.ac.uk/arrayexpress/
Nascent RNaseq in conjunction with Illumina TRUseq
method to sequence total RNAs including short lived
RNAs using highly strand-specific next-generation
sequencing (NGS) libraries
This paper E-MTAB-5115
QuantSeq libraries to study gene expression changes
in Neat1DpA compared to parental
undifferentiated hESCs
This paper Accessible via https://expressrna.org/
Fractionation RNaseq in conjunction with Illumina
TRUseq method
This paper E-MTAB-5116
RNaseq differentiation of hESCs to endoderm,
mesoderm, ectoderm, and hepatoblasts
Gifford et al., 2013 GSM1112847, GSM1112845, GSM1112846,
GSM1112844, GSM1112835, GSM1112833,
GSM1112834, GSM1112837, GSM1124072,
GSM1124072
iCLIP datasets for TDP-43 in SH-SY5Y cells Tollervey et al., 2011 E-MTAB-527 Accessible via https://www.
ebi.ac.uk/arrayexpress/
Analysis of Pro-Inflammatory Gene Activation and RNA
Processing by RNaseq of Nascent Transcripts I
GSE32916 and GSE38892, accessible via
GEO accession viewer
Mendeley dataset; Additional data composed of
Sanger sequencing and confirmatory gel
electrophoresis confirming the CRISPR-Cas9 edited
human and mouse embryonic stem cells.
This paper and Mendeley data https://data.mendeley.com/datasets/
hbr8p7n526/2
Experimental Models: Cell Lines
HEK293 Flag-WT TDP-43 tetracycline inducible Budini et al., 2015
HeLa ATCC: CCL-2 RRID: CVCL_0045
primary neonatal human dermal fibroblast (NHDF) ATCC CRL-2522
secondary human fiboblasts (HiF-Ts) Cacchiarelli et al., 2015
HAP1 ATCC 204508
hESCs H9 Wicell WB66593
V6.5 mESCs ATCC SCRC-2011
e14tg2a ICE ATCC SCRC-1029
cTdp-43 KO Ling et al., 2015
IDG3.2 Hitz et al., 2007 (C57BL/6J x
129S6/SvEvTac)F1 mESC line
Experimental Models: Organisms/Strains
Mouse: CD-1 Charles River Mouse: CD-1
Mouse: mT/mG Muzumdar et al., 2007 Mouse: mT/mG
Oligonucleotides
Stellaris smFISH Probe: Human NEAT1 Middle
Segment with Quasar 570
Stellaris SMF-2037-1-BS
Stellaris smFISH Probe: Human NEAT1 5‘ segment
conjugated to Quasar670 or Quasar570
Stellaris SMF-2036-1
Stellaris smFISH Probe: Mouse Neat1 middle segment
conjugated to Quasar670
Stellaris Customized product
Stellaris smFISH Probe: Mouse Neat1 5‘ segment
conjugated to Quasar570
Stellaris Customized product
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Stealth RNAi siRNA Thermo Fisher Scientific 12935-200
TDP-43 siRNA, 50-GGCUCAAGCAUGGAUUCUA- Dharmacon Customized product
GAPDH_F GCTCATTTCCTGGTATGACAACG
GAPDH_R GAGATTCAGTGTGGTGGGGG
OCT4_F CAATTTGCCAAGCTCCTGAAG
OCT4_R AAAGCGGCAGATGGTCGTT
MESP_F CTGCCTGAGGAGCCCAAGT
MESP_R GCAGTCTGCCAAGGAACCA
T_F CAACCTCACTGACGGTGAAAAA
T_R ACAAATTCTGGTGTGCCAAAGTT
MIXL_F CCGAGTCCAGGATCCAGGTA
MIXL_R CTCTGACGCCGAGACTTGG
SOX17_F GGCGCAGCAGAATCCAGA
SOX17_R CCACGACTTGCCCAGCAT
Lefty1_F TGTACATTGACCTGCAGGG
Lefty1_R ACTCATAAGCCAGGAAGCC
EOMES_F ACAGGAGATTTCATTCGGG
EOMES_R TTGTAAGACTATCATCTGGGTG
GDF3_F GAGACTTATGCTACGTAAAGGA
GDF3_R GGTAAAGAAAGAAACCTTGGTC
FOXD3_F CTACTACAGGGAGAAGTTCCC
FOXD3_R GTTGAGTGAGAGGTTGTGG
Neat1.screen_F GTTTGGCTTGAATGGTGCTT
Neat1.screen_R CTTCCCTCCCAGAGAGTTGA
NEAT1pA.screen_F TGAGCCAAGACTAGAGGGGA
NEAT1pA.screen_R CCTTGCTGCTCCCTTTGAAA
Neat1.screen_F GTTTGGCTTGAATGGTGCTT
Neat1.screen_R CTTCCCTCCCAGAGAGTTGA
Sox2Dmir21.screen_F TTAACGCAAAAACCGTGATG
Sox2Dmir21.screen_R GGCAGCCTGATTCCAATAAC
Neat1DTH.screen_F TTACTGCACCAGACCCTGTC
Neat1DTH.screen_R TCCTTTGGGGAACAGGAAAGAG
Gapdh_F TTCACCACCATGGAGAAGGC
Gapdh_R CCCTTTTGGCTCCACCCT
Neat1_1_F TTGGGACAGTGGACGTGTGG
Neat1_1_R TCAAGTGCCAGCAGACAGCA
Neat1_2_F GATCGGGACCCCAGTGACCT
Neat1_2_R AGCTTTCCCCAACACCCACA
mmu-mir-21 QIAGEN MIMAT0000076: 50UAG CUU AUC AGA
CUG AUG UUG A, MIMAT0004494: 50CAA
CAC CAG UCG AUG GGC UGU
TaqMan Gene Expression Assay NEAT1, isoform v2 Thermo Fisher Hs03924655_s1
TaqMan Gene Expression Assay, Gene Symbol: SOX2 Thermo Fisher Hs01053049_s1
TaqMan Gene Expression Assay, Gene Symbol:
GAPDH
Thermo Fisher Hs02758991_g1
TaqMan Gene Expression Assay, Neat1, Gene Symbol
NEAT1 isoform v1
Thermo Fisher Hs01008264_s1
TaqMan Gene Expression Assay, Gene Symbol
POU5F1
Thermo Fisher Hs00999632_g1
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
TaqMan Gene Expression Assay, Gene Symbol
SCARNA10
Thermo Fisher Hs03309805_s1
TaqMan Gene Expression Assays, gene symbol
Neat1v1
Thermo Fisher Mm03455878_s1
Recombinant DNA
pmaxGFP plasmid with insertions of modified
SOX2-UTR
Addgene 16007
PMIRH21PA-1-GVO-SBI System Biosciences PMIRH21PA-1-GVO-SBI
PX330-B/B Addgene 42230
pcDNA6/TR Addgene 5676
pCXLE-hMLN Addgene 27079
MIP 247 CoMiP 4in1 with shRNA p53. Addgene 63726
Software and Algorithms
Bowtie2 http://bowtie-bio.sourceforge.net/bowtie2/
index.shtml
TopHat2 RRID: SCR_013035; http://tophat.cbcb.
umd.edu/
STAR Dobin et al., 2013 RRID: SCR_015899; https://github.com/
alexdobin/STAR
Cufflinks RRID: SCR_014597; http://cole-trapnell-
lab.github.io/cufflinks
expressRNA Rot et al., 2017 http://www.expressrna.org/
BLAST+/2.3.0 RRID: SCR_001598; https://blast.ncbi.
nlm.nih.gov/Blast.cgi
R R Project for Statistical Computing RRID: SCR_001905; http://www.r-project.
org/
DEXseq https://github.com/roryk/DEXSeq/
Progenesis QI software version 2.0, Nonlinear Dynamics
Mascot (version 2.5.1) Matrix Science http://www.matrixscience.com/whats_
new/mascot-2-5-1-patch-release.html
EdgeR Robinson et al., 2010 https://bioconductor.org/packages/
release/bioc/html/edgeR.html
iCount http://icount.fri.uni-lj.si/
HTSeq https://htseq.readthedocs.io/en/
release_0.11.1/
Other
NEATDpA.gRNA.up.fwd CACCGATGCAAACAATTACTGTCGT
NEATDpA.gRNA.up.rev AAACACGACAGTAATTGTTTGCATC
NEATDpA.gRNA.down.fwd CACCGTGTTGAGAGTTGGTAATCAT
NEATDpA.gRNA.down.rev AAACATGATTACCAACTCTCAACAC
Neat1DpA.gRNA.up.fwd caccGAAGCTTCTTAGAATTGTCA
Neat1DpA.gRNA.up.rev aaacTGACAATTCTAAGAAGCTTC
Neat1DpA.gRNA.down.fwd caccGAGGGGAGGAAAATGGTTAGT
Neat1DpA.gRNA.down.rev aaacACTAACCATTTTCCTCCCCTC
Neat1DTDP43.gRNA.up.fwd caccgTTGTGAAAACCCTGTATATG
Neat1DTDP43.gRNA.up.rev aaacCATATACAGGGTTTTCACAAc
Neat1DTDP43.gRNA.down.fwd caccGTGAAGAAAGCTGTAACTGC
Neat1DTDP43.gRNA.down.rev aaacGCAGTTACAGCTTTCTTCAC
Sox2Dmir21_gRNA1_up caccgAGTATTTATCGAGATAAACA
Sox2Dmir21_gRNA1_down aaacTGTTTATCTCGATAAATACTc
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by Micha Drukker (micha.
drukker@helmholtz-muenchen.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
All mouse ESC lines e.g., e14tg2a, IDG3.2 (Hitz et al., 2007) and tamoxifen inducible (concentration of 1ug/mL or 2.5uM of (Z)-4-
Hydroxytamoxifen, H7904, Sigma-Aldrich) Tardbp conditional knockout (termed cTdp-43 KO (Ling et al., 2015)) were maintained on
0.1% gelatin-coated plates in 1:1 Neurobasal (21103049) DMEM (11320033) medium containing N2 (17502048) and B27 (17504044)
supplements, 1% Glutamax (35050), 1% nonessential amino acids (1140050), 0.1 mM 2-mercaptoethanol (31350-010) (all Thermo
Fisher Scientific), 1 mM MEK inhibitor PD0325901 (1408, Axon Medchem), 3 mM GSK3 inhibitor CHIR99021 (4953/50 Tocris), and
1,000 U/ml LIF (produced in-house), a condition named 2iLIF. Cells were passaged using 0.25% Trypsin-EDTA (25200056, Thermo
Fisher Scientific). Spontaneous differentiation was induced by the removing pathway inhibitors and LIF and replacing N2B27 sup-
plements with 10% HyClone Fetal Bovine Serum (FBS) (SV30160.03HI GE Healthcare). Fresh medium was applied daily.
HESCs (line H9) weremaintained in mTeSR1medium (05850, STEMCELL Technologies) onMatrigel-coated plates (356234, Corn-
ing) prepared by 1:100 dilution, and 5mL coating of 10 cm plates for 1 h at 37C. Colonies were passaged using the gentle cell disso-
ciation reagent (07174, StemCell Technologies). HESCswere differentiated by Trypsin-EDTA, dissociation to single cells and seeding
(100,000 cells/cm2) on Matrigel-coated plates in DMEM/F12 medium (11320), supplemented with 20% KnockOut Serum Replace-
ment (KSR; 10828028, Thermo Fisher Scientific), Glutamax, nonessential amino acids, and b-mercaptoethanol, or B27 supple-
mented as above with either 10 mM CHIR99021, 250ng/ml recombinant WNT3A (kindly provided by Derk ten Berge), 0.5 mM RA
(R2625, Sigma-Aldrich) or 50ng/ml BMP4 (314-BP; R&D Systems). Fresh medium was applied daily.
HEK293T Flag-WT TDP-43 tetracycline inducible cell line was cultured as previously described (Budini et al., 2015). These HEK
cells were transfected using Lipofectamine 3000 (L3000001, Thermo Fisher Scientific) according to manufacturer’s instructions.
Fresh medium was applied daily. All cells were grown at 37oC in 5% CO2.
Generation of h/mESC lines harboring edited NEAT1/Neat1
The NEAT1DpA hESC line was generated by deleting a 500 nt region surrounding the proximal pA site including the regulatory cis-
elements (Naganuma et al., 2012). Based on Raj et al. (2008) forward and reverse gRNAs (listed below) with BbsI restriction site over-
hangs were designed, phosphorylated, annealed and cloned into BbsI digested Cas9-2A-GFP vector (48138 Addgene). One million
cells were transfected with 5 mg plasmid pairs using the P3 Primary Cell 4D-Nucleofector Kit (V4XP-3012 Lonza) and the 4D-Nucle-
ofector Platform (Lonza), program CB-156. 10-14 days later clones were picked, expanded and PCR-screened for identifying clones
with alleles harboring deletions.
A similar approach was used for deleting 60 nt surrounding the proximal pA site in Neat1, 100 nt corresponding to the UGUG-rich
TDP-43 binding site in Neat1, the region corresponding to the triple helix (DTH) in Neat1_2, andmiR-21 binding site in Sox2. 53 105
mESCs were plated on 0.2% gelatin-coated wells of a 6 well plate, and were transfected 3 h later (Lipofectamine 3000, L3000008,
Thermo Fisher Scientific) with 2 mg total plasmid DNAmade of a pair of SpCas9-2A-Puro plasmids (Plasmid #62988, Addgene), each
containing single guide RNAs targeting the respective forward or reverse region in Neat1 (listed below). 48 h later the cells were re-
seeded and treated with media supplemented with 1 mg/ml puromycin (P8833, Sigma-Aldrich). 5-6 days later clones were picked,
expanded in 96-well plates and PCR-screened for identifying clones with alleles harboring deletions. Sequences of gRNAs and
primers used for generating and screening genetically edited h/mESCs are listed in the STAR Methods section
Generation of HAP-1 cells harboring edited NEAT1
PX330-B/B containing two sgRNAs (2 ug) and pcDNA6/TR (0.2 ug) containing the blasticidin resistance gene (Thermo Fisher Scien-
tific) were co-transfected into HAP1 cells (1.53 106 cells) by Nucleofector Kit V (VCA-1003, Lonza) with a Nucleofector device (Lonza)
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Sox2Dmir21_gRNA2_up caccgATTTAGGACCGTTACAAACA
Sox2Dmir21_gRNA2_down aaacTGTTTGTAACGGTCCTAAATc
Neat1DTH_gRNA1_fwd caccgaaggaagcacggtactgca
Neat1DTH_gRNA1_rev AAACtgcagtaccgtgcttccttc
Neat1DTH_gRNA2_fwd caccgAGGAAAAGAAACACCTGCGG
Neat1DTH_gRNA2_rev aaacCCGCAGGTGTTTCTTTTCCTc
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using program ‘‘X-005’’ according to the manufacturer’s instructions. To enrich the plasmid-transfected cells, the HAP1 cells were
treated with 20 ug/ml blasticidin (ant-bl-05, InvivoGen) for 3 days, starting 1 day after transfection. Subsequently, the cells were
diluted into 96-well plates for creating clones. Clones were lysed by proteinase K (200 ug/ml, 3115828001 Roche, 20 mM Tris-
HCl pH 8.0, 5 mM EDTA, 400 mM NaCl, and 0.3% SDS at 55C for 1 h, followed by proteinase K inactivation (95C for 15 min).
Then, the lysates were subjected to PCR analysis to amplify the genomic regions flanking the guide RNA target sites for detecting
deletions or insertions using KOD FX Neo enzyme (KFX-201, TOYOBO). The indel-positive clones were further confirmed by
sequencing.
Specifically, to establish HAP1 NEAT1 DUG cell line lacking three NEAT1_2 domains (5942-7025 nt, 9201-11091 nt, and 21061-
22012 nt), these domains were deleted by sequential CRISPR/Cas9-mediated deletions. First, NEAT1_2 5942-7025 nt (5.9-7 kb)
domain was deleted by sgRNAs (GGCGGGTCGTCCTAACTAGC and CATTTAAACCTTCTTCCCCG) in HAP1 WT cells. Second,
NEAT1_2 21061-22012 nt (21-22 kb) was deleted by introducing two sgRNAs (TACGCGGGGAAACGTGCCAC and TCCGACTT
CATTTCGAGTGA) into HAP1 D5.9-7 kb cells. Third, NEAT1_2 9201-11091 nt was deleted by introducing two sgRNAs (GTACCTTA
TAACGTTGGATT and TATTACCTTGGCCTAGGGGG) into HAP1 D5.9-7 kb/21-22 kb cells to establish NEAT1 DUG cell lines. To
establish HAP1 NEAT1 DUG/UGx60 cell line by knocking-in UG repeats (UG x 60) into the HAP1 NEAT1 DUG cell line, PX330-
B/B (2 ug) containing two sgRNAs targeting to knock-in vector (GCATCGTACGCGTACGTGTT) and NEAT1 genomic region
(NEAT1_2 22.1 kb region) (GCGGGCGTCTGCGTGACCTC) were co-transfected with knock-in vector (pcDNA3) containing 60 TG re-
peats (generated byGenscript) and pcDNA6/TR plasmids (0.2 ug) into HAP1NEAT1DUG cells as described above. The insertionwas
detected by PCR and further confirmed by sequencing.
Overexpression of TDP-43
A mESC line (parental e14tg2a, kindly provided by Michael Kyba) harboring doxycycline inducible iTDP-43-eGFP transgene was
generated by targeting the Rosa26 locus of the A2lox.Cre line with the p2lox (plasmid #34635, Addgene) construct cloned with
TDP-43-eGFP fusion cassette. The recombination was performed as previously described (Kyba et al., 2002), and 24 h after trans-
fection cells were selected with 250 ng/ml G418 (Invivogen, ant-gn-1) for 7 days. Clones were picked, expanded and validated. This
line was subsequently modified by deleting the 100 nt corresponding to the UGUG-rich TDP-43 binding site in Neat1. Constitutive
overexpression of TDP-43 during human fibroblast reprogramming was mediated by transduction or transfection of myc-tagged
TDP-43 (Schwenk et al., 2016). Empty vector was used as a control.
Knockdown of TDP-43
2x10^5 Accutase-treated single hESCs were seeded 24 h prior to transfection on Matrigel-coated 6-well plates with mTeSR1 me-
dium supplemented with ROCK inhibitor. Per well, siRNA transfection was performed using 5 mM siRNA duplexes mixed with 5 mL
Lipofectamine RNAiMAX (13778150, Thermo Fisher Scientific) and 100 mL DMEM, a solution incubated at RT for 20min. Dharmacon,
A-012394-14, TARDBP: 50-GGCUCAAGCAUGGAUUCUA-30 was used to target TDP-43, and a Stealth RNAi siRNA (12935-200,
Thermo Fisher Scientific) was used as the negative control. Transduction was used for knocking-down of TDP-43 via shRNAs for
global analysis of PASs in parallel to the use of a luciferase shRNA vector as a control (Schwenk et al., 2016).
Plasmids
The 30 UTR of SOX2 was ectopically express by cloning the complete UTR (1263 nt including 100 nt downstream of distal pA site)
immediately after the coding sequence of eGFP in the pmaxGFP plasmid (#16007 addgene), producing the pmaxGFP-SOX2-UTR
construct. Two variants of this plasmid were prepared by deleting themiR-21 binding site (AAATGTCCATTGTTTATAAGCTGA) pro-
ducing pmaxGFP-SOX2-UTRDmiR21, or the regulatory sequence spanning the proximal pA site (GGAAATGGGAGGGGTGCAAAA
GAGGAGAGTAAGAAACGCATGGAGAAAACCCGGTACGCTCAAAAAGAAAAAGGAAAAAAAAAAATCCCATCA) producing pmax-
GFP-SOX2UTRDpA. To ectopically expressmiR-21, the GFP sequence of plasmid PMIRH21PA-1-GVO-SBI (System Biosciences),
which codes for the microRNA precursor of miR-21, was replaced by the sequence of the gene encoding tdTomato fluorescent
protein.
Reprogramming of human fibroblasts
1.5x10^6 primary neonatal human dermal fibroblast (NHDF) (ATCC, CRL-2522) were transfected using the Nucleofector MEF 1 Kit
(VPD-1004, Lonza) with 6mg of plasmid MIP 247 CoMiP 4in1 and 3ug of pCXLE-hMLN (63726 and 27079, Addgene). Cells were
pulsed with T-020 or N-024 program using Nucleofector 2b (AAB-1001, Lonza), andwere plated onMatrigel-coated plates with fibro-
blast medium composed of DMEM high glucose (11965092, Thermo Fisher Scientific), 10% HyClone Fetal Bovine Serum
(SV30160.03HI GE Healthcare), 0.1mM sodium butyrate (B5887-250MG, Sigma Aldrich) and 64 mg/mL ascorbic acid (A8960, Sigma
Aldrich). On day 2, media was changed to Essential 7 media: DMEM/F12, (11320033), Insulin (12585014) both Thermo Fisher
Scientific, human recombinant Transferrin (T3705), Sodium selenite (S5261), Ascorbic acid 2-phosphate (A8960) by Sigma Aldrich
and FGF2, (100-18B, Peprotech), supplemented with 0.1 mM sodium butyrate, 0.1mM Hydrocortisone (H0396, Sigma Aldrich)
and 64 mg/mL ascorbic acid. Between days 10-15 first iPSC-like colonies appeared, after medium was changed to Essential 8
medium (E7 + 2ng/ml TGFbeta1) (100-21, Peprotech)) supplemented 64 mg/mL ascorbic acid in low O2 (5% O2) conditions. For
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reprogramming of secondary human fibroblasts (HiF-Ts), cells were cultured and reprogrammed as described (Cacchiarelli et al.,
2015). The number of reprogrammed colonies was analyzed by alkaline phosphatase staining (AB0300-1KT, Sigma Aldrich).
ANIMALS
Generation of chimeras
Tetraploid chimeras were generated according to standard protocols (Engert et al., 2013). Embryos were collected from the mT/mG
expressing mouse line (Muzumdar et al., 2007), maintained on C57/Bl6J background.
Animal data
Mouse keeping was done at the central facilities at HMGU in accordance with the German animal welfare legislation and acknowl-
edged guidelines of the Society of Laboratory Animals (GV-SOLAS) and of the Federation of Laboratory Animal Science Associations
(FELASA).
Immunofluorescence of embryos
Immunofluorescence whole-mount staining was performed in the following way. Briefly, embryos were isolated, fixed for 20 minutes
using 2% PFA in PBS, permeabilized using 0.1% Triton X-100 in 0.1 M glycine pH 8.0. After blocking using 10% FCS, 3% donkey
serum, 0.1% BSA, 0.1% Tween 20 for 2 h, embryos were incubated with the primary antibody o/n at 4C in blocking solution. After
several washes in PBS containing 0.1% Tween-20 (PBST) embryos were incubated with secondary antibodies (donkey anti-goat
488, donkey anti-rabbit 555 each 1:800) in blocking solution for 3 h. During the final washes with PBST, embryos were stained
with 40,6-diamidino-2-phenylindole, dihydrochloride (DAPI), transferred into 15% and 30% glycerol and embedded between two
coverslips using 120m m Secure-Seal spacers (Invitrogen, S24737) and ProLong Gold antifade reagent (Invitrogen, P36930). Anti-
bodies: Foxa2 1:1000 (Santa Cruz, sc-6554), Brachyury 1:500 (N-19, Santa Cruz, sc17743), RFP 1:1000 (Rockland, 600-401-379S).
METHOD DETAILS
RNA preparation and qRT-PCR assays
Total RNA was prepared from cell pellets using miRNeasy Micro Kit (217084, QIAGEN) according to the manufacturer’s instructions.
First-strand cDNA synthesis of 1 mg total RNA was performed using SuperScript III Reverse Transcriptase (18080085, Invitrogen),
according to the manufacturer’s guidelines. qRT-PCR reactions were performed using Power SYBR Green Master Mix (4367659,
Thermo Fisher Scientific). miR-21 was analyzed using the miScript protocol (218193, QIAGEN). Primers used in this study are listed
in the STAR Methods section
RNA sequencing
3 mg total RNAwas treated with TURBODNase (am2238, Thermo Fisher Scientific) according tomanufacturer’s instructions followed
by RNeasy MinElute RNA cleanup (74204, QIAGEN). Microcapillary electrophoresis on Agilent 2100 Bioanalyzer with RNA Pico 6000
kit (5067-1513, Agilent) was used to analyze RNA quality (RIN values > 8). For total RNA sequencing and per library, 1 mg RNA was
depleted of rRNA using RiboZero Gold (Human/Mouse/Rat) kit followed by a cleanup step and library preparation using TruSeq
Stranded Total RNA kit (RS-122-2301, Illumina) and 11 cycles of PCR, followed by purification with Agencourt AMPure XP beads
(Beckman-Coulter, A63881). Libraries were evaluated on an Agilent 2100 Bioanalyzer using the DNA 1000 kit (5067-1504, Agilent)
and DNA concentration was measured using a Qubit dsDNA HS Assay Kit (Q32854 Thermo Fisher Scientific). Samples were
sequenced using HiSeq2500 to generate 50-nt single-end reads, sequencing depth was 20–40 Mio reads per library. For
30mRNaseq, 0.5 mg DNase-treated RNA was used per library prepared using Lexogen QuantSeq-REV kit (016, Lexogen GmbH) ac-
cording to manufacturer’s instructions, and using poly(T) primer for reverse transcription. The library was sequenced using Illumina
HiSeq, producing 60 nt single-end reads.
For nascent RNA-Seq, metabolic RNA labeling in living undifferentiated hESCs was performed by adding 0.4mM EU (5-ethynyl
uridine) to the medium for 40 min. Total RNA was prepared using RNeasy MinElute RNA cleanup, and 10 mg of total RNA was treated
by Ribo-Zero Gold rRNA removal kit, and purified using RNeasyMinElute cleanup kit. rRNA-depleted, EU-labeled RNA (0.5-1 mg) was
biotinylated and captured using Click-it Nascent RNA Capture Kit (C10365, Thermo Fisher Scientific) according to manufacturer’s
instructions. Libraries were prepared using TruSeq Stranded Total RNA kit and sequenced on Illumina NexSeq 500 instrument
with 75 cycles of single-end reads.
Western blotting
Cells were trypsinized and lysed using RIPA buffer, containing phosphatase (Sigma-Aldrich, 4906837001) and protease (Merck,
539134) inhibitors. After addition of 2x SDS loading buffer with 2-Mercaptoethanol (Sigma-Aldrich, M3148) samples were heated
to 95C for 5min. Sampleswere ran onMini-PROTEAN TGXStain FreeGels, 4%–15% (Bio-Rad Laboratories, 456-8086), and blotted
using the Mini Trans-Blot Cell (Bio-Rad Laboratories, 1703930). Following 33 5 min washes with TBS-T, membranes were blocked
with 5% milk powder (T145.1, Carl Roth) in TBS-T. Membranes were then incubated o/n at 4C with 5% milk powder in TBS-T con-
taining the primary antibody. After 3 3 5 min TBS-T washes, membrane was incubated with goat anti-rabbit IgM-HRP (sc-2030,
Santa Cruz) or Goat anti-mouse IgGHRP-conjugated (115-035-003Dianova) in 5%milk powder in TBS-T. Following 4 15minwashes
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with TBS-T themembranewas incubated for 1min with ClarityWestern ECL Substrate (170-5060, Bio-Rad Laboratories) and imaged
with ChemiDoc MP System (Bio-Rad Laboratories) or exposed to X-ray film. Antibodies used are listed in the STAR Methods.
Immunofluorescence
Cells were grown in Matrigel coated 8 well chamber slides (80826, Ibidi) and fixed with 4% PFA/DPBS solution (Thermo Fisher Sci-
entific 16% Formaldehyde (w/v), Methanol-free, 28906) for 15 min at RT and permeabilized using 0.2% Triton X-100/DPBS solution
for 15 min at RT. Primary and secondary antibodies were diluted per manufacturer recommended concentrations in 10%FBS/0.2%
Triton X-100/DPBS and incubated respectively o/n at 4C and 1 h at RT. The samples were washed with DAPI (50ug/ml) solution and
imaged using a Zeiss Axiovert 200M epifluorescent microscope. Antibodies used are listed in the STAR Methods.
Flow cytometry
Plates were washed with PBS, and cells were dissociated by Trypsin-EDTA, followed by resuspension in 2% FBS 1mM EDTA PBS
buffer, and incubation with antibodies for 30-60 min on ice. Cells were centrifuged, resuspended in buffer containing SYTOX blue for
dead cell exclusion and analyzed using a FACS Aria III (BD Biosciences). Cell debris were excluded by forward and side scatter
gating. FlowJo was used for data analysis.
For intracellular flow cytometrymESCswere dissociated by Accutase (A6964, Sigma-Aldrich), centrifuged and resuspended in 2%
of methanol-free formaldehyde (28906, Thermo Fisher Scientific) for 10 min in RT. Inside Stain kit (130-090-477, Miltenyi Biotec) was
used according to manufacturer’s protocol. Antibodies used are listed in the STAR Methods.
Subcellular fractionation of hESCs
5-10^6 cells were harvested, washed with ice-cold PBS and centrifuged at 500g 4C. Cell pellets were gently resuspended in 380 mL
cold cytoplasmic lysis buffer (50 mM Tris-pH 6.5, 100 mM NaCl, 300 mM Sucrose, 3 mM MgCl2, 0.15% NP40) supplemented with
100 U RNasin Plus RNase inhibitor (PRN2615, Promega). After incubation on ice for 10 min, cells were briefly vortexed and centri-
fuged at 1000g 4C for 3 min. The supernatant containing the cytoplasmic fraction was transferred, and centrifuged again at 4C
5000g for 2 min to remove cell debris. Immediately after centrifugation 1 mL of RNA precipitation buffer (RPS; 9.5 mL 100% EtOH
with 0.5 mL 3 M Sodiumacetate) was added and the supernatant was incubated at 20C for 3 to 5 hours until further RNA
purification.
The remaining pellet was washed three timeswith 400 mL cytoplasmic lysis buffer supplemented with an increasing concentrations
50 mM, 200 mM and 500 mM of Ammonium sulfate (for disrupting the endoplasmic reticulum attached to the nucleus but without
breaking the nuclear envelope). For each washing step, the cell suspension was centrifuged at 4C and 5000 g for 2 min and the su-
pernatant was processed for RNA extraction.
380 mL of cold Modified Wuarin-Schibler (MWS) buffer (10 mM Tris-HCl pH 7.0, 4 mM EDTA, 0.3 M NaCl, 1 M Urea, 1% NP-40)
supplemented with 100 U RNasin Plus RNase inhibitor was added to the remaining pellet. Samples were vortexed for 30 s, incubated
on ice for 5 min, then vortexed again and kept on ice for 10 min. The suspension was centrifuged at 1000g 4C for 3 min and the
resulting supernatant representing the nucleoplasmic fraction was processed for RNA extraction.
The pellet was washed three times by adding 800 mL of MWS buffer, vortexing for 30 s and centrifuging at 500g 4C for 2 min. 1 mL
QIAzol (79306, QIAGEN) was added to the remaining chromatin pellet and after short vortexing, the suspension was stored at20C
until further usage.
The RNA fraction in RPS buffer was vortexed for 30 s and after adding 1 mL Glycoblue coprecipitant (Life Technologies, AM9516)
centrifuged at 18000 g 4C for 15 min. 1 mL QIAzol was added to the partially air-dried pellet. 10 mL of 0.5 M EDTA was added to all
samples and heated up to 65C and incubated for 10 min to resuspend the pellet. After cooling down, 200 mL of chloroform / isoamyl
alcohol (24:1) was added, the solution was vortexed for 30 s and then centrifuged at 18000 gRT for 10min. The upper aqueous phase
was transferred into a new tube and the same volume of isopropanol together with 1 mL of Glycoblue was added. After o/n incubation
at20C, the samples were centrifuged at 18000 gRT. The pellets were washed once by adding 1mL 70%EtOH and centrifuging at
18000 g RT for 5 min. Pellets were air-dried for 10 min and resuspended in RNase-free water. Cytoplasmic, nucleoplasmic and chro-
matin fractions were analyzed by RNA-sequencing as outlined above. Random primed, strand specific cDNA libraries were prepared
following Illumina TruSeq total RNA protocol (above). 81 – 92% of obtained reads aligned to the human genome allowing a single
mismatch.
QUANTIFICATION AND STATISTICAL ANALYSIS
Single molecule (sm)FISH and paraspeckle quantification
Based on Raj et al. (2008), h/mESCs that were grown on Matrigel coated sterile 2-well m-Slides (80286, Ibidi) were washed twice for
5 min with 1x PBS, and fixed using 4%methanol-free formaldehyde (10321714, Thermo Fisher Scientific) for 10 min at RT. Following
additional two wash steps, cells were permeabilized using 70% ethanol for 12 h at 4C, and were washed twice again. Then prep-
arations were incubated for 15 min with hybridization buffer prepared using 2x saline-sodium citrate (SSC) solution / 10% deionized
formamide (4610-OP, Calbiochem). Hybridization with Stellaris FISH probes was done in a total volume of 50 ml hybridization buffer
containing 50 mg competitor tRNA from E.coli (10109541001, Roche Diagnostics), 10% Dextran Sulfate (9011-18-1, VWR), 2 mg/ml
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UltraPure BSA (AM2616, Thermo Fisher Scientific), and 10 mM vanadyl-ribonucleoside complex (S1402S, New England BioLabs)
with probes at final concentration of 1 ng/ml. Preparations were covered with parafilm and incubated at 37C for 5 h, and afterward
washed twice with pre-warmed 2xSCC/10% formamide for 30 min at 37C. Finally the preparations were washed twice with 1x PBS
at RT, and thenmounted using 10 ml ProLong Gold Antifade Reagent containing DAPI (9071S, New England Biolabs). The slides were
imaged when the mounting medium was fully cured > 12 h.
Probes were designed using the Probe Designer software from Biosearch Technologies and were provided by same vendor.
Probes included were hNEAT1 middle segment conjugated to Quasar570 (SMF-2037-1), human NEAT1 5‘ segment conjugated
to Quasar670 or Quasar570 (SMF-2036-1), mouse Neat1 middle segment conjugated to Quasar670 and mNeat1 5‘ segment conju-
gated to Quasar570 (sequences of probes available upon request). Quantification of hybridization signal was performed using spot
detection algorithm Airlocalize (Trcek et al., 2017).
RNA-FISH and immunofluorescence
RNA-FISH - immunofluorescence was performed as previously described (Kawaguchi et al., 2015; West et al., 2016). The RNA
probes were synthesized using T7 or SP6 RNA polymerase and a digoxigenin (DIG) RNA labeling kit (11175025910, Roche). Linear-
ized plasmids (1 mg) containing a NEAT1 fragment (NEAT1 1-1000 nt) were used as templates. Cells were grown on coverslips
(Matsunami; micro cover glass; 18 mm round; thickness, 0.16–0.19 mm) and treated with 5 uM proteasome inhibitor (MG132,
Sigma-Aldrich) for 6 h to enhance NEAT1 expression (Hirose et al., 2014). Then cells were fixed with 4% paraformaldehyde/PBS
at room temperature for 10 min, washed using 1 3 PBS, permeabilized with 0.5% Triton X-100 (9002-93-1, Sigma-Aldrich)/PBS
for 5 min, and washed three times with 13 PBS. Subsequently, the cells were dipped in 100% ethanol for 5 min and then dried. De-
hydrated coverslips were incubated with pre-hybridization solution (50% formamide, 13 Denhardt’s salt, 23 SSC, 100 mM EDTA,
100 ug/ml yeast tRNA, and 0.01%Tween 20) at 55C for 1 h and then incubatedwith hybridization solution (as abovewith 5%Dextran
sulfate) containing the DIG-labeled RNA probes (final concentration: 100 ng/coverslip) at 55C o/n. After hybridization, the coverslips
were washed twice with pre-warmed wash buffer (50% formamide, 23 SSC, and 0.1% Tween 20) at 55C for 15 min. Then, excess
RNA probes were digested with 10 ug/ml RNase A (9001-99-4, Nacalai Tesque) in NTET buffer (10mMTris-HCl [pH 8.0], 1mMEDTA,
500 mM NaCl, and 0.1% Tween 20) at 37C for 30 min. The coverslips were washed with buffer (2 3 SSC and 0.01% Tween 20) at
55C for 15 min and washed twice with a second buffer (0.1 3 SSC and 0.01% Tween 20) at 55C for 15 min. The coverslips were
subsequently washed with TBST (1 3 TBS containing 0.1% Tween 20) and incubated with 1 3 blocking solution (Blocking reagent
[Roche] diluted with TBST) for blocking at RT for 1 h. Then, the coverslips were incubated with primary antibodies, Anti-Digoxigenin
mouse monoclonal antibody (clone 21H8, Abcam), Anti-TDP-43 rabbit polyclonal antibody (Proteintech, 1:100), anti-PSPC1 rabbit
polyclonal antibody (1:1000; Naganuma et al., 2012) in 1 3 blocking solution at room temperature for 1 h, washed three times
with TBST for 5 min, and incubated with secondary antibodies, anti-mouse IgG Alexa 488, and anti-rabbit IgG, Alexa-568 (both
Thermo Fisher Scientific]) in 1 3 blocking solution at RT for 30 min, and washed three times with TBST for 5 min. The coverslips
were mounted with VECTASHIELD Hard Set Mounting Medium with DAPI (Vector). Confocal images were acquired using a confocal
laser scanning microscope FV1000D (Olympus). Cells were automatically counted using Fiji software. First, nuclei or paraspeckles
were segmented using either DAPI or FISH staining to identify areas of interest. Then gausian blur (1.2) was applied and threshold for
each object was calculated using Otsu’s method. Mean intensity values or correlation coefficients were measured for the respec-
tive areas.
iCLIP protocol and its analysis
The iCLIP protocol was performed as described previously (Huppertz et al., 2014) with several modifications. Cells were irradiated by
UV once with 160 mJ/cm2 using Stratalinker 1800 at 254 nm. TDP-43 was immunoprecipitated with protein A Dynabeads (10002D,
Invitrogen) conjugated to rabbit-anti TDP-43 (Sigma-Aldrich, SAB4200006) or GFP (Life, Technologies, A6455). The region corre-
sponding to 55–100kDa complexes was excised from themembrane to isolate the RNA, and sequenced using Illumina HiSeq, gener-
ating 50-nt single-end reads, sequencing depth was 15- 20 Mio reads per library. Analysis of reproducibility of cross-linked sites,
identification of the significant iCLIP crosslinked clusters and z-score analysis of enriched pentamers was performed as described
(Tollervey et al., 2011) and data was processed by the iCount software (https://github.com/tomazc/iCount).
RNA-Seq differential expression
To identify differentially expressed genes from RNA-Seq data, sequencing reads were mapped using TopHat2 (Trapnell et al., 2009),
and gene count tables were produced using HTSeq and Ensembl genome version 74. Finally, edgeR (Robinson et al., 2010) was
applied to analyze P value and fold-expression changes.
Identification of polyA sites
QuantSeq read data were aligned to hg19 reference genome with STAR (Dobin et al., 2013). Reads that did not align uniquely were
filtered out. Identification of polyA-sites with QuantSeq relies on annealing of poly(T) primers to the polyA tails of mRNAs. To exclude
cases of internal priming, where primer anneal to genomic polyA sequences, A-rich regions in vicinity of putative polyA sites were
removed ([-10..10]). Additionally, only polyA-sites that weremore than 125 nt apart from each other were treated separately, because
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cleavage is not a nucleotide exact process, and therefore closely spaced polyA-site were pooled. PolyA site classification was done
by including those sites that were adjacent to polyA-site signals [-100, 25] nt.
polyA sites were categorized based on presence of a preceding polyA signal using polyAR (Akhtar et al., 2010). Four classes were
annotated, strong, weak, lacking polyA signal and non-categorized sites. The nucleotide composition, overlap with a published data-
set of polyA-sites (Derti et al., 2012) and efficiency of cleavage (cDNA counts) for each class of sites was analyzed, and confirmed that
strong and weak sites were the most reliable sites in terms of known nucleotide composition around polyA-sites.
Strong and weak polyA-sites were used to define position-dependent polyA-site regulation by TDP-43. Of a total 28,930 polyA
sites (strong + weak), 23,309 sites were annotated to genes (Ensembl version 74). 17,286 polyA-site exhibited strong signals across
experiments (a minimum of 10 reads needed to be detected in either test or control sample). Summing the counts across all
experiments was used as an additional filtering step to avoid sites that resulted from inefficient cleavage. Only polyA sites that ex-
hibited > 5% the level of another major site in the same gene were included. Since alternative long 30 UTRs are not yet fully annotated,
5k of the intergenic region downstream of each gene were included in this analysis (however only to the middle of the downstream
gene if distance < 5kb). This led to the identification of 16,065 sites in 10,661 genes presented in (Table S5).
Analysis of alternative polyadenylation (APA)
Genes included were those exhibiting two major pA-sites (highly expressed in both test and control). Next, pA-site pairs were clas-
sified as same-exon, composite-exon or skipped-exon. For same-exon sites, the major site was compared to the sum of all other
sites within the same exon (exon level). For composite-exon and skipped-exon pairs, the major site was compared to the expression
of the other sites in the gene.
To estimate the level of change in expression between control and test groups, we calculated the ‘‘percent change’’ (pc) score, as
follows:
pc= controlPROXIMAL=controlPROXIMAL+DISTALtestPROXIMAL=testPROXIMAL+DISTAL½1;1
Positive values determine a higher ratio of control versus test in proximal versus distal sites, and the negative values represent the
opposite trend. Fisher’s exact test was then used to determine the significance of the change. Genes were regarded as displaying
significant changes in polyA site usage between test and control is Fisher’s p value was < 0.1. Lastly genes were classified as
repressed (pc < 0.1), enhanced (pc > 0.1) and controls (abs(pc) < 0.1 and p value > 0.1). GO-term analysis of TDP-43 regulated
alternatively polyadenylated transcripts was performed based on Blake et al. (2015).
Visualizing position-dependent polyA site regulation using RNA-maps
After identifying genes exhibiting APA, summed crosslinked sites derived from iCLIP were plotted around the pA sites of repressed,
enhanced and control genes (Figures S5E–S5G). This RNA-map approach is similar to plotting RNA-maps around splice sites in alter-
native-splicing context (Ule et al., 2006; Witten and Ule, 2011).
mRNA/RBP occupancy (mRNA interactome capture)
Protocol was based on Castello et al. (2013).50X10^6 undifferentiated cells in 3 replicates of WT hESC andNEAT1DpA hESCwere
irradiated as described for iCLIP.
FASP digest
Each 10mg of RBPome were digested with a modified FASP procedure (Wisniewski et al., 2009). Briefly, the proteins were reduced
and alkylated using dithiothreitol and iodoacetamide, diluted with one volume of UA buffer (8M urea in 0.1M Tris/HCl pH 8.5) and then
centrifuged through a 30 kDa cut-off filter device (PALL, PortWashington). Samples were washed twice with UA buffer and twice with
50mMammonium bicarbonate prior to digest of the immobilized proteins on the filter for 2 h at RT using 1 mg Lys-C (WakoChemicals)
and for 16 h at 37C using 2 mg trypsin (Promega). Tryptic peptides were collected by centrifugation (10 min at 14,000 g), and the
samples were acidified with 0.5% TFA and stored at 20C.
Mass spectrometry
Before loading, the samples were centrifuged for 5 min at 4C. LC-MS/MS analysis was performed on a QExactive HF mass spec-
trometer (Thermo Scientific) online coupled to an Ultimate 3000 nano-RSLC (Thermo Scientific). Approximately 0.5 mg of every di-
gested sample was automatically injected and loaded onto the trap column at a flow rate of 30 ml/min in 3% ACN/ 0.1% FA. After
5 min, the peptides were eluted from the trap column and separated on the C18 analytical column (75 mm i.d. x 25 cm, Acclaim
PepMap100 C18.2 mm, 100A˚, Dionex) by a 90 min gradient from 5 to 25% ACN in 0.1% FA at 300 ml/min flow rate followed by a
5 min gradient from 25% to 40% ACN in 0.1% FA. Between each sample, the column was washed with 85% ACN for 5 min followed
by equilibration at 3%ACN in 0.1% FA for 18min. MS spectra were recorded at a resolution of 60000 with an AGC target of 3e6 and a
maximum injection time of 50 ms from 300 to 1500 m/z. From the MS scan, the 10 most abundant peptide ions were selected for
fragmentation via HCD with a normalized collision energy of 27, an isolation window of 1.6 m/z and a dynamic exclusion of 30 s.
MS/MS spectra were recorded at a resolution of 15000 with a AGC target of 1e5 and a maximum injection time of 50 ms. Intensity
threshold was set to 1e4and unassigned charges and charges of +1 and > 8 were excluded.
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Analysis of mRNA-interactome
Progenesis QI software (version 2.0, Nonlinear Dynamics) was used for label free quantification as described previously (Merl et al.,
2012). Briefly, profile data of the MS and MS/MS scans were transformed to peak lists with respective peak m/z values, intensities,
abundances (areas under the peaks) and m/z width. After reference selection, the retention times of the other samples were aligned
by automatic alignment to a maximal overlay of all features. After exclusion of all features with only one charge or more than seven
charges, all remaining MS/MS spectra were exported as Mascot generic file and used for peptide identification with Mascot (version
2.5.1) in the Ensembl Human protein database. Search parameters usedwere: 10 ppmpeptidemass tolerance and 20mmu fragment
mass tolerance, onemissed cleavage allowed, carbamidomethylation was set as fixedmodification, methionine oxidation and aspar-
agine or glutamine deamidation were allowed as variable modifications. A Mascot-integrated decoy database search calculated an
average false discovery of 1% when searches were performed with a mascot percolator score cut-off of 13 and an appropriate sig-
nificance threshold p. Peptide assignments were re-imported into the Progenesis QI software and the abundances of all peptides
allocated to each protein were summed up. Resulting normalized protein abundances were used further and compared to existing
mRNA-interactome datasets obtained from HeLa (Castello et al., 2012) and HEK293 cells (Baltz et al., 2012). As the aim of this study
was not to expand the repertoire of RBPs, but rather to determine the dynamics of high confidence RBPs bound to mRNAs, we used
only the overlap between published and our datasets (388 high confidence RBPs) for analysis of mRNA interactome changes upon
gain of paraspeckles in NEAT1DpA cells compared to the parental line.
DATA AND SOFTWARE AVAILABILITY
Raw sequencing files (50 nt, single-end) have been deposited in the ArrayExpress archive (accessible at E-MTAB-5090; E-MTAB-
5091; E-MTAB-5097; E-MTAB-5099; E-MTAB-5100; E-MTAB-5114, E-MTAB-5115, E-MTAB-5116) and https://expressrna.org/
platform that enables visualization and accession of the sequencing data. Similarly, iCLIP data are deposited and available also in
https://imaps.genialis.com/ and validation of CRISPR-Cas9 modified cell lines are deposited to Mendeley data (https://data.
mendeley.com/datasets/hbr8p7n526/2).
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